Terminology "Microalbuminuria" has been used to refer to albuminuria that is greater than normal (2 5-26 mg/24 hour9) but undetectable by conventional Albustix (less than 250 mg/l). It has been variously defined as an albumin concentration of between 30 and 140 ,ug/ml3; an albumin-excretion rate (AER) of between 15 and 150 pg/minute4; 20 and 200 ug/minute5; 30 and 300 mg/24 hour6; and between 26 and 250 mg/24 hour 2. Other terms in common use are "incipient diabetic nephropathy" (between 20 and 200 ug/ minute) and "clinical or overt diabetic nephropathy"7 (greater than 200 ug/minute). The proposed definitions of both terms rely on excluding other non-diabetic causes of proteinuria and should show an increased albumin excretion rate on two out of three occasions within a six month period. There is no universal agreement on these rigid criteria, which imply definite disease entities rather than evolutionary stages of one disease process. 8 The terms "microalbuminuria" and "macroalbuminuria" won't be used in this article. Both of these expressions are misleading because they suggest that albumin is present in different molecular weight forms. Although this is true in some circumstances, in nephrotic syndrome910 where polymeric and fragmentary forms of albumin occur, for example, in diabetes the "micro" and "macro" in fact refer to the amount of albumin excreted. The recently proposed neologism of "paucialbuminuria"11 also fails to provide additional clarification to the simple use of "albuminuria"'2 which is the term used in this article.
Important studies
Three prospective studies of insulin dependent diabetics have shown the prognostic value of a raised urinary albumin excretion rate (AER) with regard to subsequent nephropathy. All the authors arrived at the same conclusion-that there is a threshold rate of albumin excretion which identifies those patients likely to develop diabetic nephropathy. The important difference among these studies, however, is that each identifies a different threshold rate: Mathiesen, 70 ug/minute"; Viberti, 30 Mogensen , who has drawn attention to the six or seven year delay before the results of two large studies (diabetes control and complications trial (DCCT) and the British microalbuminuria collaborative study) are available.
Even then the question of whether strict metabolic control will prevent diabetic nephropathy may not be answered. In the meantime he recommends guidelines for patient management based on the measurement of blood pressure, glycated haemoblobin, and urinary albumin.22
Mechanisms
The pathophysiology of diabetic proteinuria has received considerable attention.223 There are, however, certain conflicting reports worthy of discussion. There should be a sound understanding of the mechanisms of albuminuria before attempting to interpret the results of measurements. Albumin in urine may come from renal and non-renal sources. Urinary tract infection has been checked as a source of proteinuria in clinical studies, but other factors including mechanical problems of the ureters, drug effects,24 and especially perineal contamination in women25 have received little attention.
The renal excretion of any substance represents a balance between glomerular filtration, tubular reabsorption, and tubular secretion. It is unlikely that any active secretion of albumin occurs in the kidney26 so that excretion is determined by the processes of filtration and reabsorption. Filtration will be influenced by glomerular filtration rate and the size and electrical charge of the molecule. More than 95 % of filtered albumin is reabsorbed by a nearly saturated tubular mechanism (direct evidence from animal studies27).
The case for increased excretion of albumin in diabetic subjects resulting from increased filtration rather than decreased tubular reabsorption' is based on the observation that the excretion of fl-2-microglobulin (an indicator of renal tubular damage) is not increased in the presence of increased albumin excretion. The excretion of y globulin, which differs in electrical charge and molecular size, is also increased, and the relative amounts of albumin and y-globulin change according to the degree of proteinuria. This suggests a progressive change in glomerular selectivity.
The excretion of fl-2-microglobulin, however, may not be the best marker of tubular function. Several studies have investigated the urinary excretion of other low molecular weight proteins (K light chains, retinol binding protein, and a-l-microglobulin). In 1979 Lopes-Virrella described a predominant excretion of low molecular weight proteins, suggesting tubular dysfunction, in juvenile diabetics with short disease duration.28 Later work on diabetics without albuminuria showed an increased excretion of K light chains which was independent of the excretion of ,B-2-microglobulin.29 Recently the excretion of retinol binding protein, a low molecular weight marker of tubular function, has been shown to be increased in diabetics with normal albumin excretion.30 A study of childhood diabetes concluded that fJ-2-microglobulin was an unsatisfactory marker of tubular function compared with the excretion of a-1-microglobulin and K light chains which were significantly increased in diabetic children.31 All ofthis work suggests that there are disturbances of tubular function which precede albuminuria, but it does not resolve the questions of which mechanism is responsible for albuminuria or whether measurement of proteins other than albumin would provide more useful information for predicting nephropathy.
Diabetic subjects have increased concentrations of glycated proteins. Non-enzymatically glycated albumin is more anionic (pl < 4 7) than the native protein, and this resulting change of charge could result in altered renal handling of glycated albumin and explain some of the changes in AER associated with improved glycaemic control. Studies of the excretion rate of glycated proteins have used various techniques and have produced contradictory results-namely, a preferential retention or excretion of glycated protein.
Gragnoli et al reported an increased renal elimination of glycated protein (expressed as nmol 5-hydroxy methyl furfural/mg protein) in diabetics which was related to the degree of proteinuria.32 Ghiggeri et al, using isoelectric focusing of chromatographically purified albumin, concluded that glycation was the main determinant of albumin excretion in diabetics with normal or slightly raised albumin excretion.33 In contrast, Kverneland et al reported a preferential retention of glycated albumin (expressed as ,umol furosine/,umol albumin), which could be explained by a loss of anionic charge on the glomerular basement membrane.34
There is an increased transcapillary escape rate (TER) of albumin in diabetic subjects.6 This was established by following the decline in plasma radioactivity after an intravenous injection of radiolabelled albumin. The TER of albumin is increased by poor metabolic control and hypertension35 and is increased in patients with increased albuminuria. The loss of albumin from the vascular compartment, however, is not explained by the increased loss of albumin in, the urine. Long term diabetics without albuminuria do not have increases in TER, suggesting that a common mechanism, probably endothelial dysfunction,36is responsible for both renal and extra-renal capillary leakage.
Whichever mechanism is responsible for the increased albumin excretion, the mainstays of clinical management will be control of hypertension and glycaemia together with the possible restriction of dietary protein. Recent The labelled antigen method is attractive because it is fast (one hour), needs only two washing steps, does not need sample predilution and has a range of 0-9-200 mg/l which is suitable for the concentrations of interest. This approach produces data which can be processed by conventional saturation analysis curve fitting procedures. "Edge effects" are recognised as a problem with microtitre plate methods454750 and refer to the discordant results that obtain in the outer wells of the microtitre plate. In practice this means better precision is achieved if only the inner 60 wells of a 96 well plate are used, a considerable sacrifice. This problem may be explained by inherent plate variability. Considering the increasing use of microtitre plate methods there have been surprisingly few rigorous investigations of these phenomena.5' Immunoturbidimetry Spencer and Price investigated kinetic immunoturbidimetry and found its performance comparable with nephelometry and therefore suitable for measuring albumin in urine at low concentrations. 52 The widespread use of centrifugal fast analysers has allowed many laboratories to have a simple, rapid, and reasonably economical method capable of dealing with large batches. The only requirement for sample pretreatment is a centrifugation step to clear the urine sample of potentially interfering particulate matter. There is no lack of either published"55 or commercially available methods. Most methods cover at least the 5-80 mg/l range and offer within and between batch precision of less than 5 and 1000, respectively. Several aspects of the technique are critical, especially the effect of polymer enhancement and antibody avridity.5' Other errors may result from the choice of instrument wavelength and the associated urine blank absorbance values.56 There is also a report of significantly different results being generated for some urines; depending on the species source of anti-albumin antibody, rabbit anti-serum produced the most reproducible results and the best correlation with an established commercial RIA.57
Radial immunodiffusion
Radial immunodiffusion (RID) methods have been used in clinical studies," and commercial systems are available. RID methods require long incubation times (often overnight) which would not permit a same day or "in clinic" service, but it is unlikely that urine albumin assays would ever be considered as urgent investigations.
Watts et al give a comprehensive comparison of RIA, RID, IT and ELISA (sandwich type). 50 They tested urine samples from diabetic patients in the range 1-120 mg/l and found no systematic difference between RIA and RID. They reported IT and ELISA as giving consistently lower values than RIA with greater random error, the errors increasing at greater albumin concentrations. ELISA gave the poorest between batch performance (CV 8-10%), and a degree of bias (a problem also encountered by others58) which was considered to be clinically significant and likely to result in the misclassification of patients. They found IT to be the most expensive method for operating cost but this was assessed against an "in house" RIA method, which is probably many times less expensive than a commercial kit. They concluded that despite the greater technical skill required, given the suitable staff, the attractions of low capital cost and the flexibility of batch size would make RID their method of choice. Another approach is a bromophenol dye binding tablet. Urine is dropped on to the surface of the tablet which is then washed by drops of distilled water. A positive reaction is given by a blue-green colour which is compared with a standard. This simple method has the major disadvantage of not being specific for albumin but reports suggest that it produces few false negative results, when used to detect urinary albumin concentrations greater than 40 mg/l and is therefore a reasonable "screening" method.6263
A laboratory assay using a colorimetric protein method has been described which gives a similar performance to other semiquantitative methods and has the advantages of speed and low cost.64
METHOD INDEPENDENT FACTORS
Potential sources of pre-analytical error include the storage conditions ofurine samples. Standards must be stable and accurately prepared. It is also important to perfoim the analysis on a representative sample and so minimise biological variations.
Albumin adherence It is known that polypeptides in urine may adsorb on to the plastic ofcontainers65 but there is no consensus regarding the behaviour of albumin in urine. Fielding et al included I% (v/v) of rabbit serum in the urine sample before storage to prevent adsorption. 45 
